Nothing Found
Sorry, no posts matched your criteria
Center for Virology and Vaccine Research
3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
CVVR Clinical Trials Unit
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu
[DISPLAY_ULTIMATE_SOCIAL_ICONS]
Vaccine Watch: Johnson and Johnson moves forward in vaccine trials
/in NewsABC News’ Bob Woodruff reports on Johnson and Johnson’s move to phase 3 trials for its vaccine, which unlike other vaccines is intended to be administered only once. Watch interview
Another COVID-19 vaccine developed in Massachusetts entering Phase 3 trial
/in NewsAfter months of laboratory work and successful testing in rhesus macaque monkeys, researchers at Johnson & Johnson and Beth Israel Deaconess Medical center are now looking for 60,000 people to […]
COVID-19 Vaccine Developed In Partnership With Beth Israel Reaches Final Stage Of Testing
/in NewsA COVID-19 vaccine developed by Johnson & Johnson in partnership with Beth Israel Deaconess Medical Center has now entered its final stage of clinical trials, making it the fourth American […]
Johnson & Johnson’s Coronavirus Vaccine Enters Phase 3 Trial With Beth Israel
/in NewsJohnson & Johnson begins large phase 3 study of COVID vaccine globally and in Boston
/in NewsRead Article
Johnson & Johnson’s COVID-19 candidate enters third trial phase
/in NewsThe company will become the first to test the simpler regimen of its candidate which is being developed by Janssen Pharmaceutical Companies, Dr. Dan Barouch, director of the Center for […]
Johnson & Johnson Begins Large Trial of Its One-Shot Vaccine
/in NewsUnlike some of its competitors, Johnson & Johnson’s vaccine does not need to be frozen and may require just one shot instead of two. Read Article
J&J kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers
/in News“The benefits of a single-shot vaccine are potentially profound in terms of mass immunization campaigns and global pandemic control,” Dr. Dan Barouch. Read Article
Major study to start for COVID-19 vaccine developed by Johnson & Johnson, Beth Israel
/in NewsUp to 60,000 volunteers, including some in Boston, will take part in the trial following encouraging data from more limited testing. Read Article
A single-shot coronavirus vaccine from Johnson & Johnson will be tested in 60,000 people
/in NewsThree other candidates have a head start, but J&J’s vaccine could be easier to administer and distribute if it is proved safe and effective. Read Article